CDER Drug Safety Labeling Changes - 5/25/2022

Drug Safety-related Labeling Changes (SrLC) The SrLC database has been updated with the following approved drug safety labeling changes. Drug Name Active Ingredient Application Number Application Type Supplement Date Database Updated CLEOCIN PHOSPHATE CLINDAMYCIN PHOSPHATE 050441 NDA 05/20/2022 05/24/2022 TYVASO TREPROSTINIL 022387 NDA 05/20/2022 05/24/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA